KURITA Naoki
- Articles
- Administration of brentuximab vedotin to a Hodgkin lymphoma patient with liver dysfunction due to vanishing bile duct syndrome resulting in a partial response without any severe adverse events
Ishitsuka Kantaro; Yokoyama Yasuhisa; Baba Naoko; Matsuok...
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY/62(3)/pp.154-157, 2022-07-12 - Cardiac Tamponade as a Recurrence of Angioimmunoblastic T-Cell Lymphoma with the Detection of a p.Gly17Val RHOA Mutation in the Pericardial Effusion
Tsuboi Yuri; Iimura Yumoe; Matsumura Fumiaki; Nanmoku ...
INTERNAL MEDICINE/62(4)/pp.595-600, 2022-06-21 - [Acquired platelet dysfunction with severe bleeding tendency in triple-negative myelofibrosis]
Momose Haruka; Nishikii Hidekazu; Kozuma Yukinori; Ota...
[Rinsho ketsueki] The Japanese journal of clinical hematology/62(9)/pp.1406-1411, 2021-09 - Salvage Cord Blood Transplantation Using a Short-term Reduced-intensity Conditioning Regimen for Graft Failure.
Suma S; Yokoyama Y; Momose H; Makishima K; Kiyoki Y; ...
INTERNAL MEDICINE/61(11)/pp.1673-1679, 2021-11 - [IgG-variant Bing-Neel syndrome diagnosed by detecting MYD88 L265P mutation in the cerebrospinal fluid cells]
Maruyama Yumiko; Nishikii Hidekazu; Matsuoka Ryota; Ma...
[Rinsho ketsueki] The Japanese journal of clinical hematology/62(10)/pp.1493-1498, 2021-10 - Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide
Kurita Naoki; Sakamoto Tatsuhiro; Kato Takayasu; Kusakabe...
Annals of hematology/100(5)/pp.1295-1301, 2021-02 - Haploidentical transplantation from a related donor as first-line treatment for fulminant aplastic anemia
槇島 健一; 長谷川 雄一; 千葉 滋; 小原 直; 坂本 竜弘; 加藤 貴康; 日下部 学; 錦井 秀和; 栗田...
Rinsho Ketsueki/61(10)/pp.1464-1468, 2020-10 - Philadelphia chromosome-positive acute lymphoblastic leukemia complicated by bone marrow necrosis during consolidation chemotherapy
Ishitsuka Kantaro; Obara Naoshi; Suyama Takuya; Matsuoka ...
Rinsho Ketsueki/61(5)/pp.462-467, 2020-05 - Salvage Cord Blood Transplantation Using a Short-Term Reduced-Intensity Preparative Regimen for Graft Failure
Suma-Sugimoto Sakurako; Yokoyama Yasuhisa; Yoshida Chika...
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA/19(1)/pp.S261-S262, 2019-09 - Prophylactic Antiemetics for Haematological Malignancies: Prospective Nationwide Survey Subset Analysis in Japan
Yoshida Isao; Tamura Kazuo; Miyamoto Toshihiro; Shimok...
In vivo (Athens, Greece)/33(4)/pp.1355-1362, 2019-07 - Fatal exacerbations of chronic active Epstein-Barr virus infection subsequent to cytotoxic chemotherapy
須摩 桜子; 横山 泰久; 坂田（柳元） 麻実子; 小原 直; 長谷川 雄一; 千葉 滋; 栗田 尚樹; 馬場 ...
Rinsho Ketsueki/60(4)/pp.286-290, 2019-04 - Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma.
K Hattori; M Sakata-Yanagimoto; Y Suehara; Y Yokoyama...
Cancer Sci/109(1)/pp.225-230, 2018 - Comparable Survival Outcomes of Haploidentical Stem Cell Transplantation and Unrelated Bone Marrow Transplantation
Sugita Junichi; Atsuta Yoshiko; Kurata Mio; Nakamae H...
BLOOD/132(1), 2018-11 - Blastic plasmacytoid dendritic cell neoplasm accompanied by chronic myelomonocytic leukemia successfully treated with azacitidine
Sukegawa Shinichiro; Sakata-Yanagimoto Mamiko; Matsuoka ...
[Rinsho ketsueki] The Japanese journal of clinical hematology/59(12)/pp.2567-2573, 2018-12 - Successful management of primary immune thrombocytopenia with romiplostim during open heart surgery in a hemodialysis patient
Nishikii Hidekazu; Kurita Naoki; Kusakabe Manabu; Yokoyam...
[Rinsho ketsueki] The Japanese journal of clinical hematology/60(1)/pp.28-32, 2019-01 - Durable Leukemic Remission and Autologous Marrow Recovery with Random Chromosomal Abnormalities after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia
Nishikii Hidekazu; Kurita Naoki; Shinagawa Atsushi; Sakam...
CASE REPORTS IN HEMATOLOGY/2019, 2019-01 - The prognosis of disseminated intravascular coagulation associated with hematologic malignancy and its response to recombinant human thrombomodulin
Kurita Naoki; Sakamoto Tatsuhiro; Kato Takayasu; Kusakabe...
Thrombosis research/173/pp.57-64, 2018-11 - Genetic evidence implies that the primary and relapsed tumors arise from common precursor cells in primary CNS lymphoma
Hattori Keiichiro; Sakata-Yanagimoto Mamiko; Kusakabe ...
Cancer science/110(1)/pp.401-407, 2018-10 - Genetic evidence implies that the primary and relapsed tumors arise from common precursor cells in primary CNS lymphoma
Hattori Keiichiro; Sakata-Yanagimoto Mamiko; Kusakabe ...
Cancer science, 2018-10-24 - Genetic evidence implies that the primary and relapsed tumors arise from common precursor cells in primary CNS lymphoma
Hattori Keiichiro; Sakata-Yanagimoto Mamiko; Kusakabe Ma...
Cancer science/110(1)/pp.401-407, 2018-11 - An Unprecedented Case of p190 BCR-ABL Chronic Myeloid Leukemia Diagnosed during Treatment for Multiple Myeloma: A Case Report and Review of the Literature
Miki Kosuke; Obara Naoshi; Makishima Kenichi; Sakamoto T...
CASE REPORTS IN HEMATOLOGY/2018/p.7863943, 2018-10 - High efficacy of eculizumab treatment for fulminant hemolytic anemia in primary cold agglutinin disease
Makishima Kenichi; Obara Naoshi; Ishitsuka Kantaro; Sukeg...
Annals of hematology/98(4)/pp.1031-1032, 2018-10 - A single institutional retrospective evaluation for younger patients with primary central nervous lymphomas on a modified R-MPV regimen followed by radiotherapy and high dose cytarabine
Hattori Keiichiro; Sakata-Yanagimoto Mamiko; Okoshi Yasu...
Journal of Clinical and Experimental Hematopathology/57(2)/pp.41-46, 2017-10 - Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma
Hattori Keiichiro; Sakata-Yanagimoto Mamiko; Suehara Yas...
Cancer science/109(1)/pp.225-230, 2018-01 - Liquid biopsy for the identification of intravascular large B-cell lymphoma
Suehara Yasuhito; Sakata-Yanagimoto Mamiko; Hattori Keii...
Haematologica/103(6)/pp.e241-e244, 2018-06 - more...
- Administration of brentuximab vedotin to a Hodgkin lymphoma patient with liver dysfunction due to vanishing bile duct syndrome resulting in a partial response without any severe adverse events